CN103636798B - A kind of preparation method of cow-goat milk mixed-type infant formula milk powder - Google Patents
A kind of preparation method of cow-goat milk mixed-type infant formula milk powder Download PDFInfo
- Publication number
- CN103636798B CN103636798B CN201310637349.1A CN201310637349A CN103636798B CN 103636798 B CN103636798 B CN 103636798B CN 201310637349 A CN201310637349 A CN 201310637349A CN 103636798 B CN103636798 B CN 103636798B
- Authority
- CN
- China
- Prior art keywords
- milk
- casein
- vitamin
- powder
- cow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000843 powder Substances 0.000 title claims abstract description 89
- 235000013350 formula milk Nutrition 0.000 title claims abstract description 61
- 235000013336 milk Nutrition 0.000 title claims description 72
- 239000008267 milk Substances 0.000 title claims description 72
- 210000004080 milk Anatomy 0.000 title claims description 72
- 238000002360 preparation method Methods 0.000 title claims description 19
- 102000011632 Caseins Human genes 0.000 claims abstract description 88
- 108010076119 Caseins Proteins 0.000 claims abstract description 88
- 239000005018 casein Substances 0.000 claims abstract description 57
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 53
- 235000021240 caseins Nutrition 0.000 claims abstract description 52
- 235000020251 goat milk Nutrition 0.000 claims abstract description 42
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 38
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 38
- 235000021247 β-casein Nutrition 0.000 claims abstract description 35
- 235000020247 cow milk Nutrition 0.000 claims abstract description 30
- 239000005862 Whey Substances 0.000 claims abstract description 27
- 235000018102 proteins Nutrition 0.000 claims abstract description 12
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 12
- 235000021119 whey protein Nutrition 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 4
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 16
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 16
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 16
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 16
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 16
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 16
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 14
- 238000000265 homogenisation Methods 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 238000000926 separation method Methods 0.000 claims description 14
- 230000001954 sterilising effect Effects 0.000 claims description 14
- 238000004659 sterilization and disinfection Methods 0.000 claims description 14
- 150000001720 carbohydrates Chemical class 0.000 claims description 12
- 235000014633 carbohydrates Nutrition 0.000 claims description 12
- 235000013325 dietary fiber Nutrition 0.000 claims description 12
- 108010058314 rennet Proteins 0.000 claims description 12
- 235000019197 fats Nutrition 0.000 claims description 11
- 229940108461 rennet Drugs 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 9
- 239000011575 calcium Substances 0.000 claims description 9
- 229910052791 calcium Inorganic materials 0.000 claims description 9
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 claims description 8
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 8
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 8
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 8
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 8
- 241000283690 Bos taurus Species 0.000 claims description 8
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 8
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 8
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 8
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 8
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 8
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 8
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 8
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 8
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 8
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 8
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 8
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 8
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 8
- 229930003268 Vitamin C Natural products 0.000 claims description 8
- 229930003316 Vitamin D Natural products 0.000 claims description 8
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 8
- 229930003427 Vitamin E Natural products 0.000 claims description 8
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 8
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 8
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 8
- 229960002685 biotin Drugs 0.000 claims description 8
- 235000020958 biotin Nutrition 0.000 claims description 8
- 239000011616 biotin Substances 0.000 claims description 8
- 239000000460 chlorine Substances 0.000 claims description 8
- 229910052801 chlorine Inorganic materials 0.000 claims description 8
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 claims description 8
- 229910052802 copper Inorganic materials 0.000 claims description 8
- 239000010949 copper Substances 0.000 claims description 8
- 229960000304 folic acid Drugs 0.000 claims description 8
- 235000019152 folic acid Nutrition 0.000 claims description 8
- 239000011724 folic acid Substances 0.000 claims description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 8
- 229960000367 inositol Drugs 0.000 claims description 8
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 8
- 239000011630 iodine Substances 0.000 claims description 8
- 229910052740 iodine Inorganic materials 0.000 claims description 8
- 229910052742 iron Inorganic materials 0.000 claims description 8
- 239000000787 lecithin Substances 0.000 claims description 8
- 229940067606 lecithin Drugs 0.000 claims description 8
- 235000010445 lecithin Nutrition 0.000 claims description 8
- 235000020778 linoleic acid Nutrition 0.000 claims description 8
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 8
- 229960004488 linolenic acid Drugs 0.000 claims description 8
- 239000011777 magnesium Substances 0.000 claims description 8
- 229910052749 magnesium Inorganic materials 0.000 claims description 8
- 229910052748 manganese Inorganic materials 0.000 claims description 8
- 239000011572 manganese Substances 0.000 claims description 8
- 229960003512 nicotinic acid Drugs 0.000 claims description 8
- 235000001968 nicotinic acid Nutrition 0.000 claims description 8
- 239000011664 nicotinic acid Substances 0.000 claims description 8
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- 229920001542 oligosaccharide Polymers 0.000 claims description 8
- 150000002482 oligosaccharides Chemical class 0.000 claims description 8
- 229940055726 pantothenic acid Drugs 0.000 claims description 8
- 235000019161 pantothenic acid Nutrition 0.000 claims description 8
- 239000011713 pantothenic acid Substances 0.000 claims description 8
- 239000011574 phosphorus Substances 0.000 claims description 8
- 229910052698 phosphorus Inorganic materials 0.000 claims description 8
- 239000011772 phylloquinone Substances 0.000 claims description 8
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 claims description 8
- 239000011591 potassium Substances 0.000 claims description 8
- 229910052700 potassium Inorganic materials 0.000 claims description 8
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 8
- 239000011669 selenium Substances 0.000 claims description 8
- 229910052711 selenium Inorganic materials 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 8
- 229910052708 sodium Inorganic materials 0.000 claims description 8
- 229960003080 taurine Drugs 0.000 claims description 8
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 8
- 235000019155 vitamin A Nutrition 0.000 claims description 8
- 239000011719 vitamin A Substances 0.000 claims description 8
- 235000019154 vitamin C Nutrition 0.000 claims description 8
- 239000011718 vitamin C Substances 0.000 claims description 8
- 235000019166 vitamin D Nutrition 0.000 claims description 8
- 239000011710 vitamin D Substances 0.000 claims description 8
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 8
- 235000019165 vitamin E Nutrition 0.000 claims description 8
- 229940046009 vitamin E Drugs 0.000 claims description 8
- 239000011709 vitamin E Substances 0.000 claims description 8
- 229940045997 vitamin a Drugs 0.000 claims description 8
- 229940046008 vitamin d Drugs 0.000 claims description 8
- 239000011701 zinc Substances 0.000 claims description 8
- 229910052725 zinc Inorganic materials 0.000 claims description 8
- 229960001231 choline Drugs 0.000 claims description 7
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 7
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 7
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 7
- 239000004615 ingredient Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 238000001694 spray drying Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 238000012986 modification Methods 0.000 claims description 5
- 230000004048 modification Effects 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 244000309466 calf Species 0.000 claims description 3
- 235000017060 Arachis glabrata Nutrition 0.000 claims 2
- 241001553178 Arachis glabrata Species 0.000 claims 2
- 235000010777 Arachis hypogaea Nutrition 0.000 claims 2
- 235000018262 Arachis monticola Nutrition 0.000 claims 2
- 235000020232 peanut Nutrition 0.000 claims 2
- 235000020256 human milk Nutrition 0.000 abstract description 14
- 210000004251 human milk Anatomy 0.000 abstract description 14
- 230000012010 growth Effects 0.000 abstract description 7
- 239000000203 mixture Substances 0.000 abstract description 6
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 4
- 230000007815 allergy Effects 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 206010010774 Constipation Diseases 0.000 abstract description 3
- 238000011161 development Methods 0.000 abstract description 3
- 206010012735 Diarrhoea Diseases 0.000 abstract description 2
- 210000000988 bone and bone Anatomy 0.000 abstract description 2
- 230000035622 drinking Effects 0.000 abstract description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 2
- 230000000423 heterosexual effect Effects 0.000 abstract description 2
- 235000016046 other dairy product Nutrition 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 10
- 239000002585 base Substances 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 229940114079 arachidonic acid Drugs 0.000 description 6
- 235000021342 arachidonic acid Nutrition 0.000 description 6
- 230000009182 swimming Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 210000002303 tibia Anatomy 0.000 description 5
- 229920002271 DEAE-Sepharose Polymers 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 102000014171 Milk Proteins Human genes 0.000 description 2
- 108010011756 Milk Proteins Proteins 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000014461 bone development Effects 0.000 description 2
- 230000008468 bone growth Effects 0.000 description 2
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000021239 milk protein Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- DAJSVUQLFFJUSX-UHFFFAOYSA-M sodium;dodecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCS([O-])(=O)=O DAJSVUQLFFJUSX-UHFFFAOYSA-M 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 210000003165 abomasum Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- MAMJNXVNGGBHFN-UHFFFAOYSA-N docosa-1,3,5,7,9,11-hexaene Chemical compound CCCCCCCCCCC=CC=CC=CC=CC=CC=C MAMJNXVNGGBHFN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 235000021125 infant nutrition Nutrition 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 238000012803 optimization experiment Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000021249 α-casein Nutrition 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种牛羊乳混合型婴幼儿配方奶粉的制备方法,是将牛乳酪蛋白进行改性,根据人乳中酪蛋白与乳清蛋白的比例,按照40:60的比例添加羊乳β-酪蛋白和脱盐乳清粉。本发明的蛋白组成和比例都更接近母乳,能显著提高婴儿机体的免疫力和抵抗力,促进婴儿的大脑、骨骼、肌肉、脂肪生长及整体的生长发育,更易消化吸收,不会引起胃部不适、婴儿饮用后不会发生便秘,不含可致过敏的异性蛋白,不会产生腹泻等乳制品过敏症状的发生,适合任何体质的婴儿,特别是胃肠较弱、体质较差的婴儿。The invention discloses a method for preparing cow's and goat's milk mixed formula milk powder for infants and young children. The cow's milk casein is modified, and goat's milk is added according to the ratio of 40:60 according to the ratio of casein and whey protein in human milk. Beta-casein and demineralized whey powder. The protein composition and ratio of the present invention are closer to breast milk, can significantly improve the immunity and resistance of the baby's body, promote the growth of the baby's brain, bones, muscles, fat and overall growth and development, are easier to digest and absorb, and will not cause stomach problems. Discomfort, babies will not suffer from constipation after drinking, it does not contain heterosexual proteins that can cause allergies, and will not cause diarrhea and other dairy product allergy symptoms. It is suitable for babies of any constitution, especially those with weak gastrointestinal tract and poor constitution.
Description
技术领域technical field
本发明涉及一种牛羊乳混合型婴幼儿配方奶粉的制备方法,属于乳制品加工技术领域。The invention relates to a method for preparing infant formula milk powder mixed with cow and goat milk, and belongs to the technical field of dairy product processing.
背景技术Background technique
母乳是新生儿最理想的天然食品,但由于受到婴幼儿或母亲的各种因素的影响,我国目前尚有30%—50%左右的婴儿无法获得母乳喂养,因此选择适宜的配方奶粉对于其生长发育十分重要。目前市售的婴幼儿配方奶粉种类繁多,大都以牛乳为主要原料,以羊乳为主要原料的配方奶粉较少。其实从婴幼儿营养的角度来看,羊乳富含多种营养成分,更接近母乳,尤其是在蛋白质的组成和性质、必需氨基酸含量、非蛋白氮组成、脂肪的性质和脂肪酸组成、低聚糖种类和含量等方面优于牛乳,乳蛋白是乳中最重要的成分,乳蛋白主要有酪蛋白和乳清蛋白2大类,羊乳和牛乳中酪蛋白的含量没有显著的差异,在酪蛋白的种类上牛乳以αs-CN为主,羊乳则以β-CN含量最多,人乳不含αs-CN,羊乳含较少的αs-CN和大量的β-CN,所以羊乳比牛乳更接近人乳。Breast milk is the most ideal natural food for newborns. However, due to the influence of various factors of infants or mothers, about 30%-50% of infants in China cannot be breast-fed at present, so choosing suitable formula milk powder is very important for their growth. Development is very important. There are many types of infant formula milk powders available on the market, most of which use cow's milk as the main raw material, and there are fewer formula milk powders with goat's milk as the main raw material. In fact, from the perspective of infant nutrition, goat milk is rich in various nutrients and is closer to breast milk, especially in terms of protein composition and properties, essential amino acid content, non-protein nitrogen composition, fat properties and fatty acid composition, and oligomerization. The type and content of sugar are superior to cow milk. Milk protein is the most important component in milk. Milk protein mainly includes casein and whey protein. There is no significant difference in the content of casein in goat milk and cow milk. In terms of protein types, cow milk is dominated by αs-CN, while goat milk has the most β-CN content. Human milk does not contain αs-CN, and goat milk contains less αs-CN and a large amount of β-CN. Cow's milk is closer to human milk.
人乳的很多特性,如较强的抗菌活性,防御感染能力、类似激素功能和免疫功能的生物活性都与β-酪蛋白紧密相关,由于牛乳β-酪蛋白含量很少,以牛乳为主要原料的婴儿配方奶粉就不具有人乳的一些相关功能。而羊乳β-酪蛋白不仅含量与人乳接近,且其结构也类似母乳,羊乳中的钙主要以酪蛋白形式存在,很容易被人体吸收。婴儿饮用易于吸收,同时不含可致过敏源,不会发生便秘,适合任何体质的婴儿,特别是胃肠较弱、体质较差的婴儿。Many properties of human milk, such as strong antibacterial activity, anti-infection ability, hormone-like function and immune function biological activities are closely related to β-casein. Infant formula milk powder does not have some related functions of human milk. Goat milk β-casein content is not only close to that of human milk, but also its structure is similar to breast milk. Calcium in goat milk mainly exists in the form of casein, which is easily absorbed by the body. It is easy for babies to drink, does not contain allergens, and will not cause constipation. It is suitable for babies of any constitution, especially those with weak gastrointestinal tract and poor constitution.
在婴儿配方奶粉方面,过去的研究都是单纯改变牛乳或者羊乳中蛋白的成分,或者人为的加入一些生物活性物质,本专利注重在原有婴儿配方奶粉的基础上,发明一种适合于0-3个月婴儿食用的新型牛羊乳混合型婴儿配方奶粉。In terms of infant formula milk powder, the past researches simply changed the protein composition of cow milk or goat milk, or artificially added some biologically active substances. This patent focuses on the original infant formula milk powder, inventing a suitable A new type of cow-goat milk mixed infant formula milk powder for 3-month-old infants.
发明内容Contents of the invention
本发明涉及一种牛羊乳混合型婴幼儿配方奶粉的制备方法,其技术方案如下:The present invention relates to a kind of preparation method of cow and goat milk mixed type infant formula milk powder, and its technical scheme is as follows:
(1)从新鲜牛乳中分离出牛乳酪蛋白,得到牛乳酪蛋白和分离液,再利用皱胃酶对牛乳酪蛋白进行水解改性;(1) Separating milk casein from fresh milk to obtain milk casein and separation liquid, and then using rennet to hydrolyze and modify milk casein;
(2)向步骤(1)得到的牛乳分离液中加入改性后的牛乳酪蛋白、羊乳β-酪蛋白和脱盐乳清粉,调节配方奶粉中酪蛋白与乳清蛋白的比例为40:60;(2) Add modified cow's milk casein, goat's β-casein and desalinated whey powder to the cow's milk separation liquid obtained in step (1), and adjust the ratio of casein to whey protein in the formula milk powder to be 40: 60;
(3)将步骤(2)中所得混合液进行均质、杀菌并干燥得到粉末状基粉;(3) Homogenize, sterilize and dry the mixed solution obtained in step (2) to obtain a powdery base powder;
(4)向步骤(3)得到的粉末状基粉中加入配料制备得到婴幼儿配方奶粉。(4) Add ingredients to the powdery base powder obtained in step (3) to prepare infant formula milk powder.
所述的制备方法中配料为:碳水化合物、膳食纤维、脂肪酸、维生素和矿物质。The ingredients in the preparation method are: carbohydrates, dietary fiber, fatty acids, vitamins and minerals.
所述的制备方法,所述配料为:能量2016kJ/100g、碳水化合物26.1g/100g、膳食纤维199mg/100g、亚油酸1925mg/100g、α-亚麻酸304mg/100g、二十二碳六烯酸6867μg/100g、花生四烯酸13.5mg/100g、维生素A469μg/100g、维生素D7.1μg/100g、维生素E4.82mg/100g、维生素K125.2μg/100g、维生素B1355μg/100g、维生素B2372μg/100g、维生素B6≥240μg/100g、维生素B12≥1.25μg/100g、维生素C45.8mg/100g、烟酸2785μg/100g、叶酸30μg/100g、泛酸2050μg/100g、低聚糖411mg/100g、卵磷脂182mg/100g、核苷酸15mg/100g、牛磺酸27mg/100g、肌醇39mg/100g、左旋肉碱8.6mg/100g、氯≤902mg/100g、生物素14.0μg/100g、胆碱43.1mg/100g、钠≤381mg/100g、锌3.41mg/100g、硒12.0μg/100g、碘44μg/100g、铜245μg/100g、锰40~44μg/100g、磷451mg/100g、钾461mg/100g、镁40.7mg/100g、钙561mg/100g、铁7.42mg/100g,其余为牛乳固形物和脂肪。The preparation method, the ingredients are: energy 2016kJ/100g, carbohydrates 26.1g/100g, dietary fiber 199mg/100g, linoleic acid 1925mg/100g, α-linolenic acid 304mg/100g, docosahexaene Acid 6867μg/100g, Arachidonic acid 13.5mg/100g, Vitamin A 469μg/100g, Vitamin D 7.1μg/100g, Vitamin E 4.82mg/100g, Vitamin K 1 25.2μg/100g, Vitamin B 1 355μg/100g, Vitamin B 2 372μg/100g, vitamin B 6 ≥240μg/100g, vitamin B 12 ≥1.25μg/100g, vitamin C 45.8mg/100g, niacin 2785μg/100g, folic acid 30μg/100g, pantothenic acid 2050μg/100g, oligosaccharides 411mg/ 100g, lecithin 182mg/100g, nucleotide 15mg/100g, taurine 27mg/100g, inositol 39mg/100g, L-carnitine 8.6mg/100g, chlorine ≤ 902mg/100g, biotin 14.0μg/100g, bile Alkali 43.1mg/100g, Sodium≤381mg/100g, Zinc 3.41mg/100g, Selenium 12.0μg/100g, Iodine 44μg/100g, Copper 245μg/100g, Manganese 40~44μg/100g, Phosphorus 451mg/100g, Potassium 461mg/100g , magnesium 40.7mg/100g, calcium 561mg/100g, iron 7.42mg/100g, and the rest are milk solids and fat.
制备方法中所述的皱胃酶为牛犊皱胃酶。The rennet described in the preparation method is calf rennet.
所述的制备方法步骤(2)中所述羊乳β-酪蛋白和脱盐乳清粉的添加量分别为20g/100g~30g/100g和30g/100g~45g/100g。The addition amounts of goat milk β-casein and desalted whey powder in step (2) of the preparation method are 20g/100g-30g/100g and 30g/100g-45g/100g respectively.
所述羊乳β酪蛋白优选的添加量为25g/100g,脱盐乳清粉优选的添加量为37.5g/100g。The preferred addition amount of goat milk β casein is 25g/100g, and the preferred addition amount of desalted whey powder is 37.5g/100g.
所述的制备方法,步骤(3)中所述的均质压力为15-20MPa,均质温度为40-50℃。In the preparation method, the homogenization pressure in step (3) is 15-20MPa, and the homogenization temperature is 40-50°C.
所述的制备方法,步骤(3)中所述的杀菌温度为82-90℃,杀菌时间为20-25s。In the preparation method, the sterilization temperature in step (3) is 82-90°C, and the sterilization time is 20-25s.
所述的制备方法,具体步骤如下:Described preparation method, concrete steps are as follows:
(1)从新鲜牛乳中分离出牛乳酪蛋白,得到牛乳酪蛋白和分离液,再利用皱胃酶对牛乳酪蛋白进行水解改性;(1) Separating milk casein from fresh milk to obtain milk casein and separation liquid, and then using rennet to hydrolyze and modify milk casein;
(2)向步骤(1)得到的牛乳分离液中加入改性后的牛乳酪蛋白、羊乳β-酪蛋白和脱盐乳清粉,所述羊乳β酪蛋白的添加量为20g/100g~30g/100g,脱盐乳清粉的添加量为30g/100g~45g/100g,调节配方奶粉中酪蛋白与乳清蛋白的比例为40:60;(2) Adding modified cow milk casein, goat milk β-casein and desalted whey powder to the milk separation liquid obtained in step (1), the amount of the goat milk β-casein added is 20g/100g~ 30g/100g, the added amount of desalted whey powder is 30g/100g~45g/100g, and the ratio of casein to whey protein in formula milk powder is adjusted to 40:60;
(3)将步骤(2)所得的混合液利用高压进行均质,均质压力为15-20MPa,均质温度为40-50℃;(3) Homogenize the mixed liquid obtained in step (2) under high pressure, the homogenization pressure is 15-20MPa, and the homogenization temperature is 40-50°C;
(4)控制杀菌温度在82-90℃,杀菌时间为20-25s;(4) Control the sterilization temperature at 82-90°C, and the sterilization time is 20-25s;
(5)采用压力顺流式多喷头干燥塔进行喷雾干燥,得到粉末状基粉;(5) Use a pressure down-flow multi-nozzle drying tower for spray drying to obtain a powdery base powder;
(6)将碳水化合物、膳食纤维、脂肪酸、维生素和矿物质与步骤(5)所得的粉末状基粉混合,获得婴幼儿配方奶粉;(6) mixing carbohydrates, dietary fiber, fatty acids, vitamins and minerals with the powdery base powder obtained in step (5) to obtain formula milk powder for infants and young children;
(7)包装。(7) Packaging.
更进一步,上述制备方法的具体步骤如下:Furthermore, the specific steps of the above-mentioned preparation method are as follows:
(1)牛乳酪蛋白改性:从新鲜牛乳中分离出牛乳酪蛋白,得到牛乳酪蛋白和分离液,再利用皱胃酶对酪蛋白进行水解改性;(1) Milk casein modification: separate milk casein from fresh milk, obtain milk casein and separation liquid, and then use rennet to hydrolyze and modify casein;
(2)调整蛋白质比例:向步骤(1)得到的牛乳分离液中加入改性后的牛乳酪蛋白、羊乳β-酪蛋白和脱盐乳清粉,所述羊乳β酪蛋白的添加量为25g/100g,脱盐乳清粉的添加量为37.5g/100g,调节配方奶粉中酪蛋白与乳清蛋白的比例为40:60;(2) Adjusting the protein ratio: adding modified cow's milk casein, goat's milk β-casein and desalted whey powder to the cow's milk separation liquid obtained in step (1), the addition amount of the goat's milk beta-casein is 25g/100g, the amount of desalted whey powder added is 37.5g/100g, and the ratio of casein to whey protein in formula milk powder is adjusted to 40:60;
(3)均质:将步骤(2)所得的混合液利用高压进行均质,均质压力为16MPa,均质温度为45℃;(3) Homogenization: The mixed solution obtained in step (2) is homogenized under high pressure, the homogenization pressure is 16MPa, and the homogenization temperature is 45°C;
(4)杀菌:控制杀菌温度在85℃,杀菌时间为24s;(4) Sterilization: Control the sterilization temperature at 85°C, and the sterilization time is 24s;
(5)喷雾干燥:采用压力顺流式多喷头干燥塔进行喷雾干燥,得到粉末状基粉;(5) Spray drying: use a pressure downstream multi-nozzle drying tower for spray drying to obtain powdery base powder;
(6)干混:将碳水化合物、膳食纤维、脂肪酸、维生素、矿物质和其他营养素与步骤(5)所得的粉末状基粉混合,获得婴幼儿配方奶粉;(6) Dry blending: mixing carbohydrates, dietary fiber, fatty acids, vitamins, minerals and other nutrients with the powdered base powder obtained in step (5) to obtain formula milk powder for infants and young children;
(7)包装:待配方奶粉排气彻底后,进行严密封口。(7) Packaging: After the formula milk powder is completely exhausted, seal it tightly.
本发明的有益效果:本发明提供的配方奶粉的蛋白组成和比例都更接近母乳。脾脏指数实验表明该新型婴儿配方奶粉能显著提高婴儿机体的免疫力和抵抗力。小鼠游泳实验数据的显示该新型婴儿配方奶粉较普通婴儿配方奶粉更具抗疲劳能力。通过大鼠的骨骼生长实验的验证,数据表明该新型婴儿配方奶粉在促进骨骼及整体的生长发育方面表现突出。通过水解牛乳固形物实验与添加羊奶β-酪蛋白实验,去除了乳中可致过敏的异性蛋白αs-酪蛋白的影响,实验结果表明新型婴幼儿配方奶粉能有有效避免腹泻等乳制品过敏症状的发生。Beneficial effects of the present invention: the protein composition and ratio of the formula milk powder provided by the present invention are closer to breast milk. Spleen index experiment shows that the new infant formula milk powder can significantly improve the immunity and resistance of the infant body. The data of the mouse swimming test showed that the new infant formula has more anti-fatigue ability than ordinary infant formula. Through the verification of bone growth experiments in rats, the data show that the new infant formula milk powder has outstanding performance in promoting bone and overall growth and development. Through hydrolyzed milk solids experiment and goat milk β-casein experiment, the influence of the allergenic heterosexual protein αs-casein in milk was eliminated. The experimental results show that the new infant formula milk powder can effectively prevent diarrhea and other dairy product allergies occurrence of symptoms.
附图说明Description of drawings
图1牛乳酪蛋白改性电泳对比图。Fig. 1 Contrast electrophoresis diagram of cow milk casein modification.
图2DEAE-Sepharose Fast Flow纯化羊乳β-酪蛋白的层析图。Figure 2 Chromatogram of goat milk β-casein purified by DEAE-Sepharose Fast Flow.
图3羊乳β-酪蛋白DEAE-Sepharose Fast Flow阴离子交换色谱洗脱峰SDS-PAGE分析图;(M:Marker;1:峰Ⅰ;2:峰Ⅱ羊乳β-酪蛋白;3:峰Ⅲ;4:峰Ⅳ)。Figure 3 SDS-PAGE analysis chart of goat milk β-casein DEAE-Sepharose Fast Flow anion exchange chromatographic elution peak; (M: Marker; 1: Peak Ⅰ; 2: Peak Ⅱ Goat milk β-casein; 3: Peak Ⅲ ; 4: Peak IV).
图4不同奶粉对大鼠骨骼生长的影响。Figure 4 Effects of different milk powders on bone growth in rats.
具体实施方式Detailed ways
材料与试剂Materials and Reagents
新鲜羊奶,采自黑龙江省绥棱县福旺奶山羊养殖场;新鲜牛乳,采自哈尔滨松花江奶牛场。健康雌性昆明一级小白鼠,45-60天龄,18-20g,由哈兽研提供。尿素,Solarbio公司;Sigma公司;胰蛋白酶,Sigma公司;氯化钠,天津市科密欧化学试剂开发中心;盐酸,天津市科密欧化学试剂开发中心;95%乙醇(v/v),美莱生物技术有限公司;过硫酸铵(AP),天津市科密欧化学试剂开发中心。Fresh goat milk is collected from Fuwang Dairy Goat Farm in Suiling County, Heilongjiang Province; fresh cow milk is collected from Harbin Songhuajiang Dairy Farm. Healthy female Kunming first-class mice, 45-60 days old, 18-20g, provided by Harbin Animal Research Institute. Urea, Solarbio Company; Sigma Company; Trypsin, Sigma Company; Sodium Chloride, Tianjin Kemiou Chemical Reagent Development Center; Hydrochloric acid, Tianjin Kemiou Chemical Reagent Development Center; 95% ethanol (v/v), the United States Lai Biological Technology Co., Ltd.; ammonium persulfate (AP), Tianjin Kemiou Chemical Reagent Development Center.
仪器与设备Instruments and Equipment
Tris、甘氨酸、十二烷基磺酸钠(SDS)、β-巯基乙醇(2-ME)、N,N’-亚甲基双丙烯酰胺、丙烯酰胺、甘油、考马斯亮蓝(CBB)R-250、过硫酸铵(AP)、溴酚蓝、盐酸、体积分数为95%乙醇、甲醇、冰乙酸均为分析纯;尿素、氯化钠和DEAE-Sepharose Fast Flow;超纯水。Tris, Glycine, Sodium Dodecyl Sulfonate (SDS), β-Mercaptoethanol (2-ME), N,N'-Methylenebisacrylamide, Acrylamide, Glycerin, Coomassie Brilliant Blue (CBB) R- 250. Ammonium persulfate (AP), bromophenol blue, hydrochloric acid, ethanol with a volume fraction of 95%, methanol, and glacial acetic acid are of analytical grade; urea, sodium chloride, and DEAE-Sepharose Fast Flow; ultrapure water.
GL-21M高速冷冻离心机;DELTA320pH计;PL2002电子天平;小型冷冻干燥机;DYY-10C型电泳仪;AKTA purifer100蛋白质纯化仪;ziptip C18层析柱。GL-21M high-speed refrigerated centrifuge; DELTA320pH meter; PL2002 electronic balance; small freeze dryer; DYY-10C electrophoresis apparatus; AKTA purifer100 protein purification apparatus; ziptip C18 chromatography column.
实施例1:牛乳酪蛋白的改性Embodiment 1: the modification of cow's milk casein
(1)皱胃酶的提取及活力测定(1) Extraction and activity determination of rennet enzyme
犊牛皱胃→清洗→细切→浸提(分三次)→过滤→透析→干燥→皱胃酶皱胃酶活力测定参见无锡酶制剂厂产品说明书。Calf abomasum→cleaning→fine cutting→extraction (three times)→filtering→dialysis→drying→Renminase rennetase activity determination, please refer to the product manual of Wuxi Enzyme Preparation Factory.
(2)牛乳酪蛋白的分离(2) Separation of cow milk casein
将新鲜牛乳离心去脂,用盐酸调节牛乳pH至4.3,收集沉淀,即为酪蛋白。Centrifuge the fresh milk to remove fat, adjust the pH of the milk to 4.3 with hydrochloric acid, and collect the precipitate, which is casein.
(3)酪蛋白的人乳化改性及优化实验(3) Human emulsification modification and optimization experiment of casein
将上一步收集的酪蛋白沉淀溶解。Dissolve the casein precipitate collected in the previous step.
酪蛋白溶液→皱胃酶作用→灭酶活→离心分离,上清液即为改性的酪蛋白,用SDS-PAGE凝胶电泳检测,发现和原酪蛋白相比,αs-酪蛋白位置的电泳谱带减弱了许多,而β酪蛋白位置的电泳谱带强度相对没有减小。这说明,经人乳化改性后的酪蛋白已成功地去除了大量的αs-酪蛋白,在此同时保留了大部分的β酪蛋白。Casein solution → rennet enzyme action → enzyme inactivation → centrifugation, the supernatant is the modified casein, detected by SDS-PAGE gel electrophoresis, it is found that compared with the original casein, the position of αs-casein The electrophoresis bands weakened a lot, but the intensity of the electrophoresis bands at the position of β casein did not decrease relatively. This shows that the casein modified by human emulsification has successfully removed a large amount of αs-casein, while retaining most of β-casein.
由上述结果可知,改性的牛乳固形物中,将牛乳中大量的、而人乳中几乎不存在,并且会成为婴儿消化吸收牛乳主要障碍的αs-酪蛋白水解掉了,并且还保留了人乳中的主要蛋白β-酪蛋白没有被水解。From the above results, it can be seen that in the modified milk solids, αs-casein, which is abundant in bovine milk but hardly exists in human milk, and which will become the main obstacle for infants to digest and absorb bovine milk, is hydrolyzed, and human αs-casein is retained. Beta-casein, the main protein in milk, is not hydrolyzed.
实施例2:羊乳β-酪蛋白的分离纯化Embodiment 2: Separation and purification of goat milk β-casein
(1)去脂肪(1) Fat removal
选择新鲜山羊乳样(10mL)在4℃10400g离心30min,样本分为三层,其中乳脂部分在上层,乳清部分在中层,乳粒部分在底部,避开上层脂质层,吸取乳清部分备用。Select fresh goat milk sample (10mL) and centrifuge at 10400g for 30min at 4°C. The sample is divided into three layers, wherein the milk fat part is in the upper layer, the whey part is in the middle layer, and the milk particle part is in the bottom layer. Avoid the upper lipid layer and absorb the whey part. spare.
(2)β-酪蛋白的分离(2) Separation of β-casein
将乳清pH调节至4.6,达到酪蛋白等电点,4℃,40000g,离心30min,收集沉淀,称100mg酪蛋白沉淀溶解于50mL的平衡缓冲液(20mmol/L的Tris,3.3mol/L的尿素),1M NaOH调节pH至9.5。样本在20℃水浴锅中间断性搅拌0.5~1h。充分溶解后,4℃,10000g离心30min,上清用0.45μm的滤膜过滤,过DEAE-Sepharose Fast Flow离子交换柱。用0.3mol/L NaCl连续梯度洗脱被吸附的蛋白质,收集A280nm处的洗脱峰。用SDS-PAGE电泳测定洗脱峰的纯度,按照性质和文献,确定峰2为羊乳β-酪蛋白并对其进行透析后冷冻干燥,。Adjust the whey pH to 4.6, reach the isoelectric point of casein, centrifuge at 40000g for 30min at 4°C, collect the precipitate, weigh 100mg of casein precipitate and dissolve in 50mL of equilibrium buffer (20mmol/L Tris, 3.3mol/L Tris urea), 1M NaOH to adjust the pH to 9.5. The samples were stirred intermittently in a water bath at 20°C for 0.5-1h. After fully dissolving, centrifuge at 10,000 g for 30 min at 4°C, filter the supernatant with a 0.45 μm filter membrane, and pass through a DEAE-Sepharose Fast Flow ion exchange column. The adsorbed protein was eluted with a continuous gradient of 0.3mol/L NaCl, and the elution peak at A 280nm was collected. The purity of the eluted peak was determined by SDS-PAGE electrophoresis. According to the properties and literature, peak 2 was determined to be goat milk β-casein, which was dialyzed and then freeze-dried.
由上述结果可知,羊乳β-酪蛋白可在体外进行分离,去除了易引起婴儿消化吸收障碍、和过敏的α-酪蛋白,婴儿饮用后不会发生便秘,适合任何体质的婴儿。From the above results, it can be seen that goat milk β-casein can be separated in vitro, and the α-casein that is easy to cause digestion and absorption disorders and allergies in babies is removed. Babies will not experience constipation after drinking it, and it is suitable for babies of any constitution.
实施例3:脱盐乳清粉的添加Embodiment 3: Addition of demineralized whey powder
模拟人乳中酪蛋白与乳清蛋白的比例,人为添加脱盐乳清粉,使配方奶粉中酪蛋白与乳清蛋白的比例为40:60。Simulating the ratio of casein to whey protein in human milk, artificially added desalted whey powder, so that the ratio of casein to whey protein in formula milk powder was 40:60.
实施例4:制备方法Embodiment 4: preparation method
以羊乳β酪蛋白的添加量为25g/100g,脱盐乳清粉的添加量为37.5g/100g为例,制备方法,具体步骤如下:Taking the addition amount of goat milk beta casein as 25g/100g and the addition amount of desalted whey powder as 37.5g/100g as an example, the specific steps of the preparation method are as follows:
(1)从新鲜牛乳中分离出牛乳酪蛋白,得到牛乳酪蛋白和分离液,再利用皱胃酶对牛乳酪蛋白进行水解改性;(1) Separating milk casein from fresh milk to obtain milk casein and separation liquid, and then using rennet to hydrolyze and modify milk casein;
(2)向步骤(1)得到的牛乳分离液中加入改性后的牛乳酪蛋白、羊乳β-酪蛋白和脱盐乳清粉,所述羊乳β酪蛋白的添加量为25g/100g,脱盐乳清粉的添加量为37.5g/100g,调节配方奶粉中酪蛋白与乳清蛋白的比例为40:60;(2) Adding modified cow milk casein, goat milk β-casein and desalted whey powder to the milk separation liquid obtained in step (1), the addition amount of the goat milk β-casein is 25g/100g, The amount of desalted whey powder added is 37.5g/100g, and the ratio of casein to whey protein in formula milk powder is adjusted to 40:60;
(3)将步骤(2)所得的混合液利用高压进行均质,均质压力为16MPa,均质温度为45℃;(3) Homogenize the mixed liquid obtained in step (2) under high pressure, the homogenization pressure is 16MPa, and the homogenization temperature is 45°C;
(4)控制杀菌温度在85℃,杀菌时间为24s;(4) Control the sterilization temperature at 85°C, and the sterilization time is 24s;
(5)采用压力顺流式多喷头干燥塔进行喷雾干燥,得到粉末状基粉;(5) Use a pressure down-flow multi-nozzle drying tower for spray drying to obtain a powdery base powder;
(6)将碳水化合物、膳食纤维、脂肪酸、维生素和矿物质与步骤(5)所得的粉末状基粉混合,获得婴幼儿配方奶粉;(6) mixing carbohydrates, dietary fiber, fatty acids, vitamins and minerals with the powdery base powder obtained in step (5) to obtain formula milk powder for infants and young children;
(7)包装。(7) Packaging.
实施例5:一种婴儿配方奶粉Embodiment 5: a kind of infant formula milk powder
一种婴幼儿配方奶粉,在原有婴幼儿配方的基础上将牛乳酪蛋白进行改性,添加羊乳β-酪蛋白和牛乳的脱盐乳清粉,模拟人乳中酪蛋白与乳清蛋白的含量,调节二者的比例为40:60。An infant formula milk powder, on the basis of the original infant formula, cow milk casein is modified, goat milk β-casein and cow milk desalted whey powder are added to simulate the content of casein and whey protein in human milk , adjust the ratio of the two to 40:60.
一种婴幼儿配方奶粉的配方为:能量2016kJ/100g、碳水化合物26.1g/100g、膳食纤维199mg/100g、亚油酸1925mg/100g、α-亚麻酸304mg/100g、二十二碳六烯酸6867μg/100g、花生四烯酸13.5mg/100g、维生素A469μg/100g、维生素D7.1μg/100g、维生素E4.82mg/100g、维生素K125.2μg/100g、维生素B1355μg/100g、维生素B2372μg/100g、维生素B6≥240μg/100g、维生素B12≥1.25μg/100g、维生素C45.8mg/100g、烟酸2785μg/100g、叶酸30μg/100g、泛酸2050μg/100g、低聚糖411mg/100g、卵磷脂182mg/100g、核苷酸15mg/100g、牛磺酸27mg/100g、肌醇39mg/100g、左旋肉碱8.6mg/100g、氯≤902mg/100g、生物素14.0μg/100g、胆碱43.1mg/100g、钠≤381mg/100g、锌3.41mg/100g、硒12.0μg/100g、碘44μg/100g、铜245μg/100g、锰40~44μg/100g、磷451mg/100g、钾461mg/100g、镁40.7mg/100g、钙561mg/100g、铁7.42mg/100g,又添加了羊乳β-酪蛋白20g/100g,脱盐乳清粉30g/100g、其余为改性后的牛奶固形物和脂肪。The formula of an infant formula milk powder is: energy 2016kJ/100g, carbohydrate 26.1g/100g, dietary fiber 199mg/100g, linoleic acid 1925mg/100g, α-linolenic acid 304mg/100g, docosahexaenoic acid 6867μg/100g, Arachidonic acid 13.5mg/100g, Vitamin A 469μg/100g, Vitamin D 7.1μg/100g, Vitamin E 4.82mg/100g, Vitamin K 1 25.2μg/100g, Vitamin B 1 355μg/100g, Vitamin B 2 372μg/100g, vitamin B 6 ≥240μg/100g, vitamin B 12 ≥1.25μg/100g, vitamin C 45.8mg/100g, niacin 2785μg/100g, folic acid 30μg/100g, pantothenic acid 2050μg/100g, oligosaccharides 411mg/100g , Lecithin 182mg/100g, Nucleotide 15mg/100g, Taurine 27mg/100g, Inositol 39mg/100g, L-Carnitine 8.6mg/100g, Chlorine≤902mg/100g, Biotin 14.0μg/100g, Choline 43.1mg/100g, sodium≤381mg/100g, zinc 3.41mg/100g, selenium 12.0μg/100g, iodine 44μg/100g, copper 245μg/100g, manganese 40~44μg/100g, phosphorus 451mg/100g, potassium 461mg/100g, Magnesium 40.7mg/100g, calcium 561mg/100g, iron 7.42mg/100g, goat milk β-casein 20g/100g, desalted whey powder 30g/100g, and the rest are modified milk solids and fat.
实施例6Example 6
一种婴幼儿配方奶粉的配方为:能量2016kJ/100g、碳水化合物26.1g/100g、膳食纤维199mg/100g、亚油酸1925mg/100g、α-亚麻酸304mg/100g、二十二碳六烯酸6867μg/100g、花生四烯酸13.5mg/100g、维生素A469μg/100g、维生素D7.1μg/100g、维生素E4.82mg/100g、维生素K125.2μg/100g、维生素B1355μg/100g、维生素B2372μg/100g、维生素B6≥240μg/100g、维生素B12≥1.25μg/100g、维生素C45.8mg/100g、烟酸2785μg/100g、叶酸30μg/100g、泛酸2050μg/100g、低聚糖411mg/100g、卵磷脂182mg/100g、核苷酸15mg/100g、牛磺酸27mg/100g、肌醇39mg/100g、左旋肉碱8.6mg/100g、氯≤902mg/100g、生物素14.0μg/100g、胆碱43.1mg/100g、钠≤381mg/100g、锌3.41mg/100g、硒12.0μg/100g、碘44μg/100g、铜245μg/100g、锰40~44μg/100g、磷451mg/100g、钾461mg/100g、镁40.7mg/100g、钙561mg/100g、铁7.42mg/100g,又添加了羊乳β-酪蛋白22.5g/100g,脱盐乳清33.75g/100g其余为改性后的牛奶固形物和脂肪。The formula of an infant formula milk powder is: energy 2016kJ/100g, carbohydrate 26.1g/100g, dietary fiber 199mg/100g, linoleic acid 1925mg/100g, α-linolenic acid 304mg/100g, docosahexaenoic acid 6867μg/100g, Arachidonic acid 13.5mg/100g, Vitamin A 469μg/100g, Vitamin D 7.1μg/100g, Vitamin E 4.82mg/100g, Vitamin K 1 25.2μg/100g, Vitamin B 1 355μg/100g, Vitamin B 2 372μg/100g, vitamin B 6 ≥240μg/100g, vitamin B 12 ≥1.25μg/100g, vitamin C 45.8mg/100g, niacin 2785μg/100g, folic acid 30μg/100g, pantothenic acid 2050μg/100g, oligosaccharides 411mg/100g , Lecithin 182mg/100g, Nucleotide 15mg/100g, Taurine 27mg/100g, Inositol 39mg/100g, L-Carnitine 8.6mg/100g, Chlorine≤902mg/100g, Biotin 14.0μg/100g, Choline 43.1mg/100g, sodium≤381mg/100g, zinc 3.41mg/100g, selenium 12.0μg/100g, iodine 44μg/100g, copper 245μg/100g, manganese 40~44μg/100g, phosphorus 451mg/100g, potassium 461mg/100g, Magnesium 40.7mg/100g, calcium 561mg/100g, iron 7.42mg/100g, goat milk β-casein 22.5g/100g, desalted whey 33.75g/100g and the rest are modified milk solids and fat.
实施例7Example 7
一种婴幼儿配方奶粉的配方为:能量2016kJ/100g、碳水化合物26.1g/100g、膳食纤维199mg/100g、亚油酸1925mg/100g、α-亚麻酸304mg/100g、二十二碳六烯酸6867μg/100g、花生四烯酸13.5mg/100g、维生素A469μg/100g、维生素D7.1μg/100g、维生素E4.82mg/100g、维生素K125.2μg/100g、维生素B1355μg/100g、维生素B2372μg/100g、维生素B6≥240μg/100g、维生素B12≥1.25μg/100g、维生素C45.8mg/100g、烟酸2785μg/100g、叶酸30μg/100g、泛酸2050μg/100g、低聚糖411mg/100g、卵磷脂182mg/100g、核苷酸15mg/100g、牛磺酸27mg/100g、肌醇39mg/100g、左旋肉碱8.6mg/100g、氯≤902mg/100g、生物素14.0μg/100g、胆碱43.1mg/100g、钠≤381mg/100g、锌3.41mg/100g、硒12.0μg/100g、碘44μg/100g、铜245μg/100g、锰40~44μg/100g、磷451mg/100g、钾461mg/100g、镁40.7mg/100g、钙561mg/100g、铁7.42mg/100g,又添加了羊乳β-酪蛋白25g/100g,脱盐乳清37.5g/100g其余为改性后的牛奶固形物和脂肪。The formula of an infant formula milk powder is: energy 2016kJ/100g, carbohydrate 26.1g/100g, dietary fiber 199mg/100g, linoleic acid 1925mg/100g, α-linolenic acid 304mg/100g, docosahexaenoic acid 6867μg/100g, Arachidonic acid 13.5mg/100g, Vitamin A 469μg/100g, Vitamin D 7.1μg/100g, Vitamin E 4.82mg/100g, Vitamin K 1 25.2μg/100g, Vitamin B 1 355μg/100g, Vitamin B 2 372μg/100g, vitamin B 6 ≥240μg/100g, vitamin B 12 ≥1.25μg/100g, vitamin C 45.8mg/100g, niacin 2785μg/100g, folic acid 30μg/100g, pantothenic acid 2050μg/100g, oligosaccharides 411mg/100g , Lecithin 182mg/100g, Nucleotide 15mg/100g, Taurine 27mg/100g, Inositol 39mg/100g, L-Carnitine 8.6mg/100g, Chlorine≤902mg/100g, Biotin 14.0μg/100g, Choline 43.1mg/100g, sodium≤381mg/100g, zinc 3.41mg/100g, selenium 12.0μg/100g, iodine 44μg/100g, copper 245μg/100g, manganese 40~44μg/100g, phosphorus 451mg/100g, potassium 461mg/100g, Magnesium 40.7mg/100g, calcium 561mg/100g, iron 7.42mg/100g, goat milk β-casein 25g/100g, desalted whey 37.5g/100g and the rest are modified milk solids and fat.
实施例8Example 8
一种婴幼儿配方奶粉的配方为:能量2016kJ/100g、碳水化合物26.1g/100g、膳食纤维199mg/100g、亚油酸1925mg/100g、α-亚麻酸304mg/100g、二十二碳六烯酸6867μg/100g、花生四烯酸13.5mg/100g、维生素A469μg/100g、维生素D7.1μg/100g、维生素E4.82mg/100g、维生素K125.2μg/100g、维生素B1355μg/100g、维生素B2372μg/100g、维生素B6≥240μg/100g、维生素B12≥1.25μg/100g、维生素C45.8mg/100g、烟酸2785μg/100g、叶酸30μg/100g、泛酸2050μg/100g、低聚糖411mg/100g、卵磷脂182mg/100g、核苷酸15mg/100g、牛磺酸27mg/100g、肌醇39mg/100g、左旋肉碱8.6mg/100g、氯≤902mg/100g、生物素14.0μg/100g、胆碱43.1mg/100g、钠≤381mg/100g、锌3.41mg/100g、硒12.0μg/100g、碘44μg/100g、铜245μg/100g、锰40~44μg/100g、磷451mg/100g、钾461mg/100g、镁40.7mg/100g、钙561mg/100g、铁7.42mg/100g,又添加了羊乳β-酪蛋白27.5g/100g,脱盐乳清粉41.25g/100g、其余为改性后的牛奶固形物和脂肪。The formula of an infant formula milk powder is: energy 2016kJ/100g, carbohydrate 26.1g/100g, dietary fiber 199mg/100g, linoleic acid 1925mg/100g, α-linolenic acid 304mg/100g, docosahexaenoic acid 6867μg/100g, Arachidonic acid 13.5mg/100g, Vitamin A 469μg/100g, Vitamin D 7.1μg/100g, Vitamin E 4.82mg/100g, Vitamin K 1 25.2μg/100g, Vitamin B 1 355μg/100g, Vitamin B 2 372μg/100g, vitamin B 6 ≥240μg/100g, vitamin B 12 ≥1.25μg/100g, vitamin C 45.8mg/100g, niacin 2785μg/100g, folic acid 30μg/100g, pantothenic acid 2050μg/100g, oligosaccharides 411mg/100g , Lecithin 182mg/100g, Nucleotide 15mg/100g, Taurine 27mg/100g, Inositol 39mg/100g, L-Carnitine 8.6mg/100g, Chlorine≤902mg/100g, Biotin 14.0μg/100g, Choline 43.1mg/100g, sodium≤381mg/100g, zinc 3.41mg/100g, selenium 12.0μg/100g, iodine 44μg/100g, copper 245μg/100g, manganese 40~44μg/100g, phosphorus 451mg/100g, potassium 461mg/100g, Magnesium 40.7mg/100g, calcium 561mg/100g, iron 7.42mg/100g, goat milk β-casein 27.5g/100g, desalted whey powder 41.25g/100g, and the rest are modified milk solids and Fat.
实施例9Example 9
一种婴幼儿配方奶粉的配方为:能量2016kJ/100g、碳水化合物26.1g/100g、膳食纤维199mg/100g、亚油酸1925mg/100g、α-亚麻酸304mg/100g、二十二碳六烯酸6867μg/100g、花生四烯酸13.5mg/100g、维生素A469μg/100g、维生素D7.1μg/100g、维生素E4.82mg/100g、维生素K125.2μg/100g、维生素B1355μg/100g、维生素B2372μg/100g、维生素B6≥240μg/100g、维生素B12≥1.25μg/100g、维生素C45.8mg/100g、烟酸2785μg/100g、叶酸30μg/100g、泛酸2050μg/100g、低聚糖411mg/100g、卵磷脂182mg/100g、核苷酸15mg/100g、牛磺酸27mg/100g、肌醇39mg/100g、左旋肉碱8.6mg/100g、氯≤902mg/100g、生物素14.0μg/100g、胆碱43.1mg/100g、钠≤381mg/100g、锌3.41mg/100g、硒12.0μg/100g、碘44μg/100g、铜245μg/100g、锰40~44μg/100g、磷451mg/100g、钾461mg/100g、镁40.7mg/100g、钙561mg/100g、铁7.42mg/100g,又添加了羊乳β-酪蛋白30g/100g,脱盐乳清粉45g/100g、其余为改性后的牛奶固形物和脂肪。The formula of an infant formula milk powder is: energy 2016kJ/100g, carbohydrate 26.1g/100g, dietary fiber 199mg/100g, linoleic acid 1925mg/100g, α-linolenic acid 304mg/100g, docosahexaenoic acid 6867μg/100g, Arachidonic acid 13.5mg/100g, Vitamin A 469μg/100g, Vitamin D 7.1μg/100g, Vitamin E 4.82mg/100g, Vitamin K 1 25.2μg/100g, Vitamin B 1 355μg/100g, Vitamin B 2 372μg/100g, vitamin B 6 ≥240μg/100g, vitamin B 12 ≥1.25μg/100g, vitamin C 45.8mg/100g, niacin 2785μg/100g, folic acid 30μg/100g, pantothenic acid 2050μg/100g, oligosaccharides 411mg/100g , Lecithin 182mg/100g, Nucleotide 15mg/100g, Taurine 27mg/100g, Inositol 39mg/100g, L-Carnitine 8.6mg/100g, Chlorine≤902mg/100g, Biotin 14.0μg/100g, Choline 43.1mg/100g, sodium≤381mg/100g, zinc 3.41mg/100g, selenium 12.0μg/100g, iodine 44μg/100g, copper 245μg/100g, manganese 40~44μg/100g, phosphorus 451mg/100g, potassium 461mg/100g, Magnesium 40.7mg/100g, calcium 561mg/100g, iron 7.42mg/100g, goat milk β-casein 30g/100g, desalted whey powder 45g/100g, and the rest are modified milk solids and fat.
实施例10新型配方奶粉提高免疫力实验Embodiment 10 Novel formula milk powder improves immunity experiment
取45~60天龄的小白鼠(全母),分为对照组、试验组1、试验2,3个组别,每组10只,共30只,分别灌服生理盐水、普通奶粉、实施例6新型婴儿配方奶粉(浓度均为1g/ml)4mL/只,每日一次,连续用药10d,然后将对照组实验组1实验组2用脊椎脱臼法处死小白鼠,称量体重,取出脾脏称量。以脾脏重量/mg与体重/g之比作为脾脏指数。不同制剂对小鼠脾脏指数的影响如表1所示。Take 45-60-day-old mice (whole mother), divide them into control group, test group 1, test 2, 3 groups, 10 in each group, a total of 30 mice, respectively fed with normal saline, ordinary milk powder, and implement Example 6 New infant formula milk powder (concentration is 1g/ml) 4mL/mouse, once a day, continuous medication for 10 days, then kill the mice in the control group, experimental group 1, experimental group 2 by spinal dislocation, weigh the mice, and take out the spleen weighing. The ratio of spleen weight/mg to body weight/g was used as the spleen index. The effects of different preparations on the spleen index of mice are shown in Table 1.
表1不同奶粉对小鼠脾脏指数的影响Table 1 Effects of different milk powders on the spleen index of mice
如表1所示,经过数据分析发现,对照组和试验2组之间的脾脏指数差异极显著(p<0.01);对照组和试验组1之间的脾脏指数有显著的差异(p<0.05)。As shown in Table 1, after data analysis, it was found that the spleen index difference between the control group and the test group 2 was extremely significant (p<0.01); the spleen index between the control group and the test group 1 had a significant difference (p<0.05 ).
从以上实验看,在饲料中加入普通婴儿配方奶粉后与新型配方奶粉收,都可显著提高小鼠的脾脏指数,但是加入新型配方奶粉后脾脏指数增加更多,说明该新型配方奶粉较普通婴儿配方奶粉更能提高免疫力。From the above experiments, the spleen index of mice can be significantly increased after adding ordinary infant formula milk powder and new formula milk powder in the feed, but the spleen index increases more after adding new formula milk powder, indicating that the new formula milk powder is more effective than ordinary infant formula. Formula milk powder can improve immunity even more.
实施例11新型配方奶粉抗疲劳实验Embodiment 11 novel formula milk powder anti-fatigue experiment
游泳实验将小白鼠按照表1连续灌胃10天,最后一次灌胃后60min,分别称量体重。然后将2.0g的重物系于小白鼠尾根部,再将小白鼠放入在45cm×30cm×20cm、水温18.5℃的水池中游泳,开始计时。当小白鼠头部沉入水中10s不能浮出水面即为体力耗竭,即刻计时,为小白鼠游泳时间,不同制剂对小鼠游泳时间的影响如表2所示。Swimming test The mice were gavaged continuously for 10 days according to Table 1, and their body weights were weighed 60 minutes after the last gavage. Then tie a 2.0g weight to the base of the tail of the mouse, put the mouse into a swimming pool with a size of 45cm×30cm×20cm and a water temperature of 18.5°C, and start timing. When the mouse’s head was submerged in the water for 10 seconds and could not emerge from the water, it was considered to be physically exhausted. Timed immediately, it was the swimming time of the mouse. The effects of different preparations on the swimming time of the mice are shown in Table 2.
表2不同奶粉对小鼠游泳时间的影响Table 2 Effects of different milk powders on the swimming time of mice
以上实验说明,该新型婴儿配方奶粉较普通婴儿配方奶粉在抗疲劳方面有明显提高。The above experiments show that the new infant formula milk powder has obvious improvement in anti-fatigue compared with ordinary infant formula milk powder.
实施例12新型配方奶粉促进骨骼发育实验Example 12 Novel formula milk powder promotes bone development experiment
选取3周龄清洁级纯系雄性SD大鼠用普通饲料喂养4周后,强行灌喂0.8g/d,灌胃10天。对照组为灌胃生理盐水的实验组,实验组1和实验组2分别为灌胃普通配方奶粉和新型婴儿配方奶粉的实验组。灌胃第6天,腹腔里注射荧光基质-四环素,第8天进行荧光基质-四环素第2次注射,第10天麻醉大鼠致死,完整剥离出胫骨,用游标卡尺测量胫骨近端关节面和远端关节面之间的距离,即为喂食10d的胫骨长度,取其3次测量的平均值,结果如图4所示。图4显示对照组0胫骨生长长度为65μm,实验组1胫骨生长长度为75μm,实验组2胫骨生长长度为82μm,新型婴儿配方奶粉在促进骨骼发育方面表现显著。Select 3-week-old clean-grade pure-line male SD rats and feed them with common feed for 4 weeks, then force-feed 0.8g/d for 10 days. The control group was the experimental group fed with normal saline, the experimental group 1 and the experimental group 2 were the experimental groups fed with common formula milk powder and new infant formula milk powder, respectively. On the 6th day of intragastric administration, the fluorescent matrix-tetracycline was injected intraperitoneally, and the second injection of the fluorescent matrix-tetracycline was performed on the 8th day. On the 10th day, the rats were anesthetized to death, and the tibia was completely stripped out. The distance between the end articular surfaces is the length of the tibia after feeding for 10 days, and the average value of three measurements is taken, and the results are shown in Figure 4. Figure 4 shows that the growth length of the tibia in the control group 0 was 65 μm, the growth length of the tibia in the experimental group 1 was 75 μm, and the growth length of the tibia in the experimental group 2 was 82 μm. The new infant formula has a significant performance in promoting bone development.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310637349.1A CN103636798B (en) | 2013-12-03 | 2013-12-03 | A kind of preparation method of cow-goat milk mixed-type infant formula milk powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310637349.1A CN103636798B (en) | 2013-12-03 | 2013-12-03 | A kind of preparation method of cow-goat milk mixed-type infant formula milk powder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103636798A CN103636798A (en) | 2014-03-19 |
| CN103636798B true CN103636798B (en) | 2015-10-21 |
Family
ID=50242212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310637349.1A Expired - Fee Related CN103636798B (en) | 2013-12-03 | 2013-12-03 | A kind of preparation method of cow-goat milk mixed-type infant formula milk powder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103636798B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104012659B (en) * | 2014-06-26 | 2016-04-20 | 中恩(天津)营养科技有限公司 | A kind of formula powder for PKU children and preparation method thereof |
| CN105053204A (en) * | 2015-07-24 | 2015-11-18 | 林晓萍 | Administration method of premature infant milk powder for promoting bone growth and development of premature infant |
| CN105076425A (en) * | 2015-09-17 | 2015-11-25 | 许德建 | Yak, cow and ewe three-in-one composite infant formula milk powder |
| CN107397230A (en) * | 2017-08-21 | 2017-11-28 | 杭州特悘衡康生物科技有限公司 | Alimentation composition, the formula food for promoting Post operation muscle recovery and protein synthesis and its application |
| CA3097360A1 (en) * | 2018-04-19 | 2019-10-24 | Ellie LLC | Sample clarification and reduction of background fluorescence for fluorescent detection of analytes |
| WO2021003741A1 (en) * | 2019-07-11 | 2021-01-14 | 北京三元食品股份有限公司 | APPLICATION OF β-CASEIN A2 AND COMPOSITION THEREOF IN PROMOTING PROLIFERATION OF BIFIDOBACTERIUM |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1656906A (en) * | 2005-03-16 | 2005-08-24 | 石家庄三鹿集团股份有限公司 | Formulated milk powder for children and its preparation method |
| CN1656905A (en) * | 2005-03-16 | 2005-08-24 | 石家庄三鹿集团股份有限公司 | Formulated milk powder for infantile and preparation method |
| CN102283289A (en) * | 2011-09-15 | 2011-12-21 | 澳优乳业(中国)有限公司 | Anti-inflaming infant formula milk powder and preparation process thereof |
| CN102763727A (en) * | 2012-07-02 | 2012-11-07 | 李晓林 | Dairy cattle and goat milk composite infant formula milk powder |
-
2013
- 2013-12-03 CN CN201310637349.1A patent/CN103636798B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1656906A (en) * | 2005-03-16 | 2005-08-24 | 石家庄三鹿集团股份有限公司 | Formulated milk powder for children and its preparation method |
| CN1656905A (en) * | 2005-03-16 | 2005-08-24 | 石家庄三鹿集团股份有限公司 | Formulated milk powder for infantile and preparation method |
| CN102283289A (en) * | 2011-09-15 | 2011-12-21 | 澳优乳业(中国)有限公司 | Anti-inflaming infant formula milk powder and preparation process thereof |
| CN102763727A (en) * | 2012-07-02 | 2012-11-07 | 李晓林 | Dairy cattle and goat milk composite infant formula milk powder |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103636798A (en) | 2014-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103636798B (en) | A kind of preparation method of cow-goat milk mixed-type infant formula milk powder | |
| AU2019411230B2 (en) | Nutritional composition for inducing a feeling of satiety, a better sleep and/or limiting nocturnal awaking in infants or young children | |
| TW201200033A (en) | Nutritional emulsions comprising calcium HMB and soluble protein | |
| CN103369975A (en) | Whey protein composition with a reduced astringency | |
| TWI629994B (en) | Use of nutritional compositions including lactoferrin in stimulating immune cells | |
| EP2661180B1 (en) | Composition comprising heat labile milk proteins and process for preparing same | |
| JP2008512398A (en) | Human milk fortifier and its manufacturing method | |
| WO2019104390A1 (en) | Milk substitute compositions | |
| CN117355227A (en) | Infant formula containing breast milk protein | |
| WO2017211858A1 (en) | Heat sterilized high protein enteral compositions with whey protein which comprises whey protein micelles and a source of casein | |
| CN101179953B (en) | Food composition for stimulating growth, comprising fraction isolated from mammalian colostrum or milk whey | |
| CN107529805A (en) | Composition comprising choline and its derivative, preparation method and use | |
| CN120732160A (en) | Infant nutrition containing hydrolyzed protein and palmitic acid | |
| KR101640890B1 (en) | Composition of infant liquid formula including goat milk | |
| RU2575178C2 (en) | Composition, containing thermolabile milk proteins and method for obtaining thereof | |
| RU2810219C2 (en) | Nutritional composition to promote feelings of satiety, better sleep and/or limit night wakings in infants or young children | |
| CN109874870A (en) | A kind of infant milk powder of simulation breast milk proteins composition and immune function | |
| RU2575776C2 (en) | Application of lactoferrin-containing nutritional compositions for stimulation of immune cells | |
| KR20170021726A (en) | Composition of infant liquid formula including goat milk | |
| CN113973921A (en) | Goat milk powder beneficial to rapid protein absorption and preparation method thereof | |
| NZ756828B2 (en) | Lactoferrin and sialic acid-modulated milk powder and preparation method thereof | |
| NZ756828A (en) | Lactoferrin and sialic acid-modulated milk powder and preparation method thereof | |
| HK1189769A (en) | Composition comprising heat labile milk proteins and process for preparing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151021 |